Literature DB >> 34458433

Isolation of Peripheral Blood Mononuclear Cells Using Vacutainer® Cellular Preparation Tubes (CPTTM).

Alaina Puleo1, Chantia Carroll1, Holden T Maecker1, Rohit Gupta1.   

Abstract

Peripheral blood mononuclear cell (PBMC) isolation is commonly done via density gradient centrifugation over Ficoll-Hypaque, a labor-intensive procedure that requires skilled technicians and can contribute to sample variability. Cellular Preparation Tubes (CPTs) are Vacutainer blood draw tubes that contain Ficoll-Hypaque and a gel plug that separates the Ficoll solution from the blood to be drawn. Once blood is drawn into CPTs, they can be centrifuged to separate the PBMC, then shipped (if desired) to a processing lab. The processing lab removes the PBMC from the upper compartment of the tube (above the gel plug), washes the PBMC, and can cryopreserve them using DMSO-containing media, as detailed in this protocol.
Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Blood; CPT; Cell preparation; Ficoll; PBMC; Stabilization

Year:  2017        PMID: 34458433      PMCID: PMC8376597          DOI: 10.21769/BioProtoc.2103

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  3 in total

1.  Evaluation of a novel mononuclear cell isolation procedure for serological HLA typing.

Authors:  P Schlenke; H Klüter; M Müller-Steinhardt; H J Hammers; K Borchert; G Bein
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

2.  VACUTAINER CPT and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples.

Authors:  Joyce J Ruitenberg; Candice B Mulder; Vernon C Maino; Alan L Landay; Smita A Ghanekar
Journal:  BMC Immunol       Date:  2006-05-25       Impact factor: 3.615

3.  Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT™) and standard density gradient.

Authors:  Christopher P Corkum; Danielle P Ings; Christopher Burgess; Sylwia Karwowska; Werner Kroll; Tomasz I Michalak
Journal:  BMC Immunol       Date:  2015-08-26       Impact factor: 3.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.